RxSight
RXST
RXST
157 hedge funds and large institutions have $299M invested in RxSight in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 55 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
9.86% less ownership
Funds ownership: 91.09% → 81.23% (-9.9%)
30% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 46
38% less capital invested
Capital invested by funds: $481M → $299M (-$182M)
Holders
157
Holding in Top 10
1
Calls
$690K
Puts
$715K
Top Buyers
| 1 | +$11.2M | |
| 2 | +$5.21M | |
| 3 | +$4.93M | |
| 4 |
D.E. Shaw & Co
New York
|
+$4.61M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.27M |
Top Sellers
| 1 | -$48.1M | |
| 2 | -$11.6M | |
| 3 | -$9.46M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.83M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$5.02M |
